Cargando...

What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients?

AIM: To investigate optimal timing for therapeutic efficacy of entecavir for acute-on-chronic hepatitis B liver failure (ACLF-HBV) in hepatitis B e antigen (HBeAg)-negative patients. METHODS: A total of 109 inpatients with ACLF-HBV were recruited from the Department of Infectious Diseases of the Thi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yan, Ying, Mai, Li, Zheng, Yu-Bao, Zhang, Shao-Quan, Xu, Wen-Xiong, Gao, Zhi-Liang, Ke, Wei-Min
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Co., Limited 2012
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3435788/
https://ncbi.nlm.nih.gov/pubmed/22969236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i33.4604
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!